Diagnostic Accuracy of Endoscopic Ultrasound-guided Fine Needle Aspiration Cytology of Pancreatic Lesions
Overview
Affiliations
Background: Endoscopic ultrasound-guided fine needle aspiration cytology (EUS-FNAC) is currently the most commonly used procedure for obtaining cytologic specimens of the pancreas. It is accurate, minimally invasive, safe and cost-effective. However, there is discrepancy between cytological and surgical diagnoses. This study was aimed at evaluating the diagnostic accuracy of EUS-FNAC of the pancreas.
Methods: We performed a retrospective review of 191 cases of pancreatic lesions initially diagnosed by EUS-FNAC with subsequent histological diagnosis between 2010 and 2012 in the Department of Pathology, Seoul National University Hospital. Cytologic and surgical diagnoses were categorized into five groups: negative, benign, atypical, malignant, and insufficient for diagnosis. Subsequently, 167 cases with satisfactory yield in both surgical and cytology specimens were statistically analyzed to determine correlations with diagnosis.
Results: In comparison to surgical diagnoses, cytologic diagnoses were true-positive in 103 cases (61.7%), true-negative in 28 cases (16.8%), false-positive in 9 cases (5.4%), and false-negative in 27 cases (16.1%). The diagnostic accuracy was 78.4%, sensitivity was 79.2%, and specificity was 75.7%. The positive predictive value was 92.0%, and negative predictive value was 50.9%.
Conclusions: EUS-FNAC has high accuracy, sensitivity, specificity and positive predictive value. Overcoming the limitations of EUS-FNAC will make it a useful and reliable diagnostic tool for accurate evaluation of pancreatic lesions.
Ueda H, Takahashi H, Kobayashi S, Kubo M, Sasaki K, Iwagami Y Ann Surg Oncol. 2024; 32(2):720-735.
PMID: 39269634 DOI: 10.1245/s10434-024-16115-w.
Jaleel R, George J, Thomas A, Patel L, John A, Kurien R Ann Gastroenterol. 2024; 37(3):371-376.
PMID: 38779649 PMC: 11107408. DOI: 10.20524/aog.2024.0879.
Reporting Pancreatic FNAC using the Papanicolaou System: Still a Diagnostic Challenge.
Verma P, Goyal S, Tyagi R, Ghuman M, Mahajan R, Selhi A J Cytol. 2024; 41(2):123-130.
PMID: 38779600 PMC: 11108040. DOI: 10.4103/joc.joc_90_23.
Garcia-Ortiz M, Cano-Ramirez P, Toledano-Fonseca M, Aranda E, Rodriguez-Ariza A Biomark Res. 2023; 11(1):88.
PMID: 37798621 PMC: 10552233. DOI: 10.1186/s40364-023-00528-y.
Zhang W, Campbell D, Walsh B, Packer N, Liu D, Wang Y J Nanobiotechnology. 2022; 20(1):446.
PMID: 36242076 PMC: 9563798. DOI: 10.1186/s12951-022-01641-0.